Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

Major Program
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
ECOG-ACRIN Cancer Research Group
Active, not recruiting ID
For more information, see NCT03804255
This trial assesses current biomarker testing practices for common solid cancers in precision
oncology in the community setting. Cancer biomarkers are used for diagnosing the disease,
determining prognosis, predicting response to a targeted therapy, or monitoring response to
therapy. Testing quality, including accuracy and timeliness, is imperative for correct
disease prognosis and identification of patients who may or may not benefit from a targeted
therapy. Assessing current biomarker testing practices may help doctors identify gaps and
variations in testing as well as on potential ?best practices? that may be informative and
generalizable to community oncology programs.
Survey Administration
Breast Carcinoma, Colorectal Carcinoma, Community Practice, Lung Carcinoma, Melanoma, Solid Neoplasm
Julia Trosman

See list of participating sites